Clinical trials
Weight Loss trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
180 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 6 |
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 7 |
| 2014 | 5 |
| 2015 | 11 |
| 2016 | 15 |
| 2017 | 5 |
| 2018 | 10 |
| 2019 | 17 |
| 2020 | 19 |
| 2021 | 15 |
| 2022 | 17 |
| 2023 | 21 |
| 2024 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 180 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Miriam Hospital | 5 |
| Hospital General Universitario Elche | 3 |
| Laval University | 3 |
| Mansoura University | 3 |
| Universidad de Sonora | 3 |
| University of Illinois at Urbana-Champaign | 3 |
| American University of Beirut Medical Center | 2 |
| National University Hospital, Singapore | 2 |
| Oregon Health and Science University | 2 |
| ReShape Lifesciences | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Weight Loss | 180 |
| Obesity | 98 |
| Overweight | 28 |
| Obesity, Morbid | 12 |
| Diabetes Mellitus | 9 |
| Diabetes Mellitus, Type 2 | 9 |
| Metabolic Syndrome | 7 |
| Malnutrition | 6 |
| Non-alcoholic Fatty Liver Disease | 6 |
| Insulin Resistance | 5 |
Trials
Showing 76 to 100 of 180. Each trial links to its page on Pharma Observatory.
80 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.